Beta Wealth Group, Inc. Milestone Pharmaceuticals Inc. Transaction History
Beta Wealth Group, Inc.
- $206 Million
- Q4 2024
A detailed history of Beta Wealth Group, Inc. transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Beta Wealth Group, Inc. holds 14,127 shares of MIST stock, worth $30,796. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,127
Previous 14,127
-0.0%
Holding current value
$30,796
Previous $21,000
57.14%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MIST
# of Institutions
52Shares Held
25.2MCall Options Held
61.2KPut Options Held
38.8K-
Black Rock Inc. New York, NY4.97MShares$10.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.7MShares$5.89 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$5.8 Million2.16% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$5.46 Million0.1% of portfolio
-
Orbimed Advisors LLC San Diego, CA2MShares$4.36 Million0.13% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $65.4M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...